aOX40 (GSK3174998)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for aOX40 (GSK3174998), covering 2024-03-12 to 2024-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM [Phase 1, Phase 2]